Diabetes Mellitus Type 2 in Obese, Type 2 Diabetes Mellitus With Features of Insulin Resistance
Conditions
Keywords
Percutaneous neurostimulation; dermatome T7, type 2 diabetes
Brief summary
Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas and improves glycemic profile in diabetic patients
Interventions
DEVICEPercutaneous Neurostimulation (PENS) of dermatome T7
The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
OTHER1200 Kcal diet
Sponsors
Hospital General Universitario Elche
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* BMI\>30 Kg/m2 * Type 2 diabetes mellitus * Treatment with Metformin
Exclusion criteria
* Under insulin treatment * Endocrinological disorders causing diabetes mellitus
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum glucose levels (mg/dl) | Baseline and 12 weeks after beginning the therapy | Serum glucose levels will be recorded will be recorded at baseline and 12 weeks after beginning the treatment. Measurement units will be mg/dl. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Homeostasis model assessment (HOMA) | Baseline and 12 weeks after beginning the therapy | Insulin resistance will be recorded by the Homeostasis model assessment (HOMA). The calculation formula is: Serum Glucose x Serum Insulin / 405 |
Countries
Spain
Outcome results
None listed